Ropinirole Prolonged ReleaseIn Advanced Parkinson’s Disease

被引:0
|
作者
Juliane Weber
Gillian M. Keating
机构
[1] Wolters Kluwer Health ∣ Adis,
[2] Wolters Kluwer Health,undefined
来源
CNS Drugs | 2009年 / 23卷
关键词
Levodopa; Ropinirole; Rotigotine; Levodopa Dosage; ReQuip;
D O I
暂无
中图分类号
学科分类号
摘要
▴ Ropinirole prolonged release is a non-ergoline dopamine receptor agonist that is indicated for the treatment of Parkinson’s disease.
引用
收藏
页码:81 / 90
页数:9
相关论文
共 50 条
  • [41] Higher Proportion of Responders on the Clinical Global Impression - Improvement Scale with Ropinirole Prolonged Release Compared with Ropinirole Immediate Release in Patients with Advanced Parkinson's Disease
    Shulman, Kenneth
    Rolfe, Katie
    Stocchi, Fabrizio
    NEUROLOGY, 2010, 74 (09) : A354 - A354
  • [42] Ropinirole prolonged release maintains a reduction in daily awake time spent "off" in patients with advanced Parkinson's disease (PD)
    Stocchi, F.
    Hunter, B.
    Giorgi, L.
    Hersh, B.
    EUROPEAN JOURNAL OF NEUROLOGY, 2009, 16 : 555 - 555
  • [43] High-dose ropinirole in advanced Parkinson's disease with severe dyskinesias
    Cristina, S
    Zangaglia, R
    Mancini, F
    Martignoni, E
    Nappi, G
    Pacchetti, C
    CLINICAL NEUROPHARMACOLOGY, 2003, 26 (03) : 146 - 150
  • [44] The effectiveness of pramipexole in early and advanced Parkinson's disease and comparison of the results with ropinirole
    Karakaya, F.
    Ozturk, S.
    Ceviz, I.
    Kusbeci, O. Yilmaz
    EUROPEAN JOURNAL OF NEUROLOGY, 2012, 19 : 668 - 668
  • [45] Improvements in awake time spent "on" throughout the day in patients with advanced Parkinson's disease treated with adjunctive ropinirole prolonged release
    Chaudhuri, K. R.
    Rolfe, K.
    Lipschitz, A.
    Cooper, J.
    MOVEMENT DISORDERS, 2010, 25 (07) : S294 - S294
  • [46] An open-label extension study to evaluate the safety of ropinirole prolonged release in Chinese patients with advanced Parkinson's disease
    Zhang, Zhenxin
    Wang, Jian
    Zhang, Xiaoying
    Chen, Shengdi
    Wang, Zhenfu
    Zhang, Baorong
    Liu, Chunfeng
    Qu, Qiumin
    Cheng, Yan
    Zhu, Rongxuan
    Li, Jie
    Hu, Jingqiu
    Cai, Meng
    CURRENT MEDICAL RESEARCH AND OPINION, 2015, 31 (04) : 723 - 730
  • [47] Improvements in Awake Time Spent "On" throughout the Day in Patients with Advanced Parkinson's Disease Treated with Adjunctive Ropinirole Prolonged Release
    Cooper, James
    Rolfe, Katie
    Lipschitz, Alan
    Chaudhuri, K. Ray
    NEUROLOGY, 2010, 74 (09) : A353 - A353
  • [48] Pharmacokinetic and Pharmacodynamic Comparison of Ropinirole 24-Hour Prolonged Release and Ropinirole Immediate Release in Patients With Parkinson's Disease
    Tompson, Debra
    Oliver-Willwong, Ruth
    CLINICAL NEUROPHARMACOLOGY, 2009, 32 (03) : 140 - 148
  • [49] Open-Label Conversion Study of Pramipexole to Ropinirole Prolonged Release in Parkinson's Disease
    Lyons, Kelly E.
    Pahwa, Rajesh
    MOVEMENT DISORDERS, 2009, 24 (14) : 2121 - 2127
  • [50] Early Treatment Benefits of Ropinirole Prolonged Release in Parkinson's Disease Patients with Motor Fluctuations
    Hersh, Bonnie P.
    Earl, Nancy L.
    Hauser, Robert A.
    Stacy, Mark
    MOVEMENT DISORDERS, 2010, 25 (07) : 927 - 931